Skip to main content

Advertisement

Log in

A new metabolic pathway of arsenite: arsenic–glutathione complexes are substrates for human arsenic methyltransferase Cyt19

  • Inorganic Compounds
  • Published:
Archives of Toxicology Aims and scope Submit manuscript

Abstract

The metabolism of arsenic is generally accepted to proceed by repetitive reduction and oxidative methylation; the latter is mediated by arsenic methyltransferase (Cyt19). In human urine, the major metabolites of inorganic arsenicals such as arsenite (iAsIII) and arsenate (iAsV) are monomethylarsonic acid (MMAV) and dimethylarsinic acid (DMAV). On the other hand, in rat bile, the major metabolites of iAsIII have been reported to be arsenic–glutathione (As-GSH) complexes. In the present study we investigate whether these As-GSH complexes are substrates for arsenic methyltransferase by using human recombinant Cyt19. Analyses by high-performance liquid chromatography–inductively coupled plasma mass spectrometry suggested that arsenic triglutathione (ATG) was generated nonenzymatically from iAsIII when GSH was present at concentrations 2 mM or higher. Human recombinant Cyt19 catalyzed transfer of a methyl group from S-adenosyl-l-methionine to arsenic and produced monomethyl and dimethyl arsenicals. The methylation of arsenic was catalyzed by Cyt19 only when ATG was present in the reaction mixture. Moreover, monomethylarsonic diglutathione (MADG) was a substrate of Cyt19 for further methylation to dimethylarsinic glutathione (DMAG). On the other hand, monomethylarsonous acid (MMAIII), a hydrolysis product of MADG, was not methylated to dimethyl arsenical by Cyt19. These results suggest that As-GSH complexes such as ATG and MADG were converted by Cyt19 to MADG and DMAG, respectively. Both MADG and DMAG were unstable in solution when the GSH concentration was lower than 1 mM, and were hydrolyzed and oxidized to MMAV and DMAV, respectively. Metabolism of iAsIII to methylated arsenicals by Cyt19 was via ATG and MADG rather than by oxidative methylation of iAsIII and MMAIII.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3A–C
Fig. 4A,B
Fig. 5
Fig. 6A–D
Fig. 7A–D
Fig. 8 A
Fig. 9

Similar content being viewed by others

References

  • Aposhian HV (1997) Enzymatic methylation of arsenic species and other new approaches to arsenic toxicity. Annu Rev Pharmacol Toxicol 37:397–419

    Article  CAS  PubMed  Google Scholar 

  • Aposhian HV, Gurzau ES, Le XC, Gurzau A, Healy SM, Lu X, Ma M, L Yip, Zakharyan RA, Maiorino RM, Dart RC, Tircus MG, Gonzalez Ramirez D, Morgan DL, Avram D, Aposhian MM (2000) Occurrence of monomethylarsonous acid in urine of humans exposed to inorganic arsenic. Chem Res Toxicol 13:693–697

    Article  CAS  PubMed  Google Scholar 

  • Aposhian HV, Zakharyan RA, Avram MD, Kopplin MJ, Wollenberg ML (2003) Oxidation and detoxification of trivalent arsenic species. Toxicol Appl Pharmacol 193:1–8

    Article  CAS  PubMed  Google Scholar 

  • Buchet JP, Lauwerys R (1985) Study of inorganic arsenic methylation by rat-liver in vitro—relevance for the interpretation of observations in man. Arch Toxicol 57:125–129

    CAS  PubMed  Google Scholar 

  • Buchet JP, Lauwerys R (1987) Study of factors influencing the in vivo methylation of inorganic arsenic in rats. Toxicol Appl Pharmacol 91:65–74

    Article  CAS  PubMed  Google Scholar 

  • Buchet JP, Lauwerys R (1988) Role of thiols in the in vitro methylation of inorganic arsenic by rat-liver cytosol. Biochem Pharmacol 37:3149–3153

    Article  CAS  PubMed  Google Scholar 

  • Crecelius EA (1977) Changes in the chemical speciation of arsenic following ingestion by man. Environ Health Perspect 19:147–150

    CAS  PubMed  Google Scholar 

  • Engel RR, Smith AH (1994) Arsenic in drinking-water and mortality from vascular-disease—an ecologic analysis in 30 counties in the United States. Arch Environ Health 49:418–427

    CAS  PubMed  Google Scholar 

  • Hansen HR, Raab A, Jaspars M, Milne BF,Feldmann J (2004) Sulfur-containing arsenical mistaken for dimethylarsinous acid [DMA(III)] and identified as a natural metabolite in urine: major implications for studies on arsenic metabolism and toxicity. Chem Res Toxicol 17:1086–1091

    Article  CAS  PubMed  Google Scholar 

  • Hirano S, Cui X, Li S, Kanno S, Kobayashi Y, Hayakawa T, Shraim A (2003) Difference in uptake and toxicity of trivalent and pentavalent inorganic arsenic in rat heart microvessel endothelial cells. Arch Toxicol 77:305–312

    CAS  PubMed  Google Scholar 

  • Hirano S, Kobayashi Y, Cui X, Kanno S, Hayakawa T, Shraim A (2004) The accumulation and toxicity of methylated arsenicals in endothelial cells: important roles of thiol compounds. Toxicol Appl Pharmacol 198:458–467

    Article  CAS  PubMed  Google Scholar 

  • Hu CJ, Zhang AH, Huang HH (2003) Molecular pathology of skin carcinogenesis due to arsenicalism from coal-burning. Arch Environ Health 58:92–96

    CAS  PubMed  Google Scholar 

  • Kala SV, Neely MW, Kala G, Prater CI, Atwood DW, Rice JS, Lieberman MW (2000) The MRP2/cMOAT transporter and arsenic-glutathione complex formation are required for biliary excretion of arsenic. J Biol Chem 275:33404–33408

    Article  CAS  PubMed  Google Scholar 

  • Kato K, Yamanaka K, Hasegawa A, Okada S (2003) Active arsenic species produced by GSH-dependent reduction of dimethylarsinic acid cause micronuclei formation in peripheral reticulocytes of mice. Mutat Res 539:55–63

    Article  CAS  PubMed  Google Scholar 

  • Lin S, Shi Q, Nix FB, Styblo M, Beck MA, Herbin-Davist KM, Hall LL, Simeonsson JB, Thomas DJ (2002) A novel S-adenosyl-l-methionine: arsenic(III) methyltransferase from rat liver cytosol. J Biol Chem 277:10795–10803

    Article  CAS  PubMed  Google Scholar 

  • Mandal BK, Ogra Y, Suzuki KT (2001) Identification of dimethylarsinous and monomethylarsonous acids in human urine of the arsenic-affected areas in West Bengal, India. Chem Res Toxicol 14:371–378

    Article  CAS  PubMed  Google Scholar 

  • Nemeti B, Gregus Z (2002) Reduction of arsenate to arsenite in hepatic cytosol. Toxicol Sci 70:4–12

    Article  CAS  PubMed  Google Scholar 

  • Petrick JS, Ayala-Fierro F, Cullen WR, Carter DE, Aposhian HV (2000) Monomethylarsonous acid (MMA(III)) is more toxic than arsenite in Chang human hepatocytes. Toxicol Appl Pharmacol 163:203–207

    Article  CAS  PubMed  Google Scholar 

  • Radabaugh TR, Sampayo-Reyes A, Zakharyan RA, Aposhian HV (2002) Arsenate reductase II. Purine nucleoside phosphorylase in the presence of dihydrolipoic acid is a route for reduction of arsenate to arsenite in mammalian systems. Chem Res Toxicol 15:692–698

    Article  CAS  PubMed  Google Scholar 

  • Reay PF, Asher CJ (1977) Preparation and purification of 74As-labeled arsenate and arsenite for use in biological experiments. Anal Biochem 78:557–560

    CAS  PubMed  Google Scholar 

  • Sampayo-Reyes A, Zakharyan RA, Healy SM, Aposhian HV (2000) Monomethylarsonic acid reductase and monomethylarsonous acid in hamster tissue. Chem Res Toxicol 13:1181–1186

    Article  CAS  PubMed  Google Scholar 

  • Scott N, Hatlelid KM, Mackenzie NE, Carter DE (1993) Reactions of arsenic(III) and arsenic(V) species with glutathione. Chem Res Toxicol 6:102–106

    CAS  PubMed  Google Scholar 

  • Shraim A, Sekaran NC, Anuradha CD, Hirano S (2002) Speciation of arsenic in tube-well water samples collected from West Bengal, India, by high-performance liquid chromatography-inductively coupled plasma mass spectrometry. Appl Organomet Chem 16:202–209

    Article  CAS  Google Scholar 

  • Shraim A, Cui X, Li S, Ng JC, Wang HP, Jin YL, Liu YC, Guo L, Li DS, Wang SQ, Zhang RZ, Hirano S (2003) Arsenic speciation in the urine and hair of individuals exposed to airborne arsenic through coal-burning in Guizhou, PR China. Toxicol Lett 137:35–48

    Article  CAS  PubMed  Google Scholar 

  • Styblo M, Thomas DJ (1997) Binding of arsenicals to proteins in an in vitro methylation system. Toxicol Appl Pharmacol 147:1-8

    Article  CAS  PubMed  Google Scholar 

  • Styblo M, Delnomdedieu M, Thomas DJ (1996) Mono- and dimethylation of arsenic in rat liver cytosol in vitro. Chem Biol Int 99:147–164

    Article  CAS  Google Scholar 

  • Styblo M, Del Razo LM, Vega L, Germolec DR, LeCluyse EL, Hamilton GA, Reed W, Wang C, Cullen WR, Thomas DJ (2000) Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells. Arch Toxicol 74:289–299

    Article  CAS  PubMed  Google Scholar 

  • Suzuki KT, Mandal BK, Katagiri A, Sakuma Y, Kawakami A, Ogra Y, Yamaguchi K, Sei Y, Yamanaka K, Anzai K, Ohmichi M, Takayama H, Aimi N (2004) Dimethylthioarsenicals as arsenic metabolites and their chemical preparations. Chem Res Toxicol 17:914–921

    Article  CAS  PubMed  Google Scholar 

  • Tam GKH, Charbonneau SM, Bryce F, Pomroy C, Sandi E (1979) Metabolism of inorganic arsenic (74As) in humans following oral ingestion. Toxicol Appl Pharmacol 50:319–322

    Article  CAS  PubMed  Google Scholar 

  • Vahter M, Marafante E, Dencker L (1984) Tissue distribution and retention of As-74-dimethylarsinic acid in mice and rats. Arch Environ Contam Toxicol 13:259–264

    CAS  PubMed  Google Scholar 

  • Walton FS, Waters SB, Jolley SL, LeCluyse EL, Thomas DJ, Styblo M (2003) Selenium compounds modulate the activity of recombinant rat As-III-methyltransferase and the methylation of arsenite by rat and human hepatocytes. Chem Res Toxicol 16:261–265

    Article  CAS  PubMed  Google Scholar 

  • Waters SB, Devesa V, Del Razo LM, Styblo M, Thomas DJ (2004) Endogenous reductants support the catalytic function of recombinant rat Cyt19, an arsenic methyltransferase. Chem Res Toxicol 17:404–409

    Article  CAS  PubMed  Google Scholar 

  • Wildfang E, Radabaugh TR, Aposhian HV (2001) Enzymatic methylation of arsenic compounds. IX. Liver arsenite methyltransferase and arsenate reductase activities in primates. Toxicology 168:213–221

    Article  CAS  PubMed  Google Scholar 

  • Yamanaka K, Mizoi M, Tachikawa M, Hasegawa A, Hoshino M, Okada S (2003) Oxidative DNA damage following exposure to dimethylarsinous iodide: the formation of cis-thymine glycol. Toxicol Lett 143:145–153

    Article  CAS  PubMed  Google Scholar 

  • Yamauchi H, Yamamura Y (1984) Metabolism and excretion of orally-administered dimethylarsinic acid in the hamster. Toxicol Appl Pharmacol 74:134–140

    Article  CAS  PubMed  Google Scholar 

  • Zakharyan RA, Aposhian HV (1999) Arsenite methylation by methylvitamin B-12 and glutathione does not require an enzyme. Toxicol Appl Pharmacol 154:287–291

    Article  CAS  PubMed  Google Scholar 

  • Zakharyan RA, Sampayo-Reyes A, Healy SM, Tsaprailis G, Board PG, Liebler DC, Aposhian HV (2001) Human monomethylarsonic acid (MMAV) reductase is a member of the glutathione-S-transferase superfamily. Chem Res Toxicol 14:1051–1057

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This study was partially supported by Grant-in-aid for Scientific Research (14390058) from The Japan Society for Promotion of Science.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Seishiro Hirano.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hayakawa, T., Kobayashi, Y., Cui, X. et al. A new metabolic pathway of arsenite: arsenic–glutathione complexes are substrates for human arsenic methyltransferase Cyt19. Arch Toxicol 79, 183–191 (2005). https://doi.org/10.1007/s00204-004-0620-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00204-004-0620-x

Keywords

Navigation